Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.
W F Owen Jr, … , J Petersen, K F Austen
W F Owen Jr, … , J Petersen, K F Austen
Published June 1, 1991
Citation Information: J Clin Invest. 1991;87(6):1958-1963. https://doi.org/10.1172/JCI115222.
View: Text | PDF
Research Article

Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

  • Text
  • PDF
Abstract

Normodense eosinophils failed to generate leukotriene C4 (LTC4) in response to incremental concentrations of FMLP but did produce LTC4 when stimulated with calcium ionophore A23187. Normodense eosinophils, maintained in culture with 10(-11) M granulocyte/macrophage colony-stimulating factor (GM-CSF) in the presence of 3T3 fibroblasts, became responsive to transmembrane stimulation with FMLP by day 4 with a maximal effect by day 7. After 7 d of culture, hypodense eosinophils stimulated with 2 x 10(-7) M FMLP generated 26 ng LTC4/10(6) cells, and LTC4 biosynthesis was blocked by N-tertbutoxy-carbonyl-L-methionyl-L-leucyl-L-phenylalanine (N-t-BOC-MLP). Neither calcium ionophore stimulation of LTC4 from endogenous arachidonic acid nor substrate-initiated production of LTC4 from incorporated LTA4 changed when eosinophils were cocultured with GM-CSF and 3T3 fibroblasts. Furthermore, when incubated with 10(-6) M FMLP, normodense eosinophils generated no net superoxide measured by the reduction of cytochrome c, whereas replicate eosinophils cultured for 7 d with 10(-11) M GM-CSF and 3T3 fibroblasts reduced a net of 17 nmol of cytochrome c/10(6) cells. These studies suggest that primed and phenotypically altered eosinophils present at an extravascular site may exert pathobiologic effects by responding to soluble ligands in the tissues.

Authors

W F Owen Jr, J Petersen, K F Austen

×

Total citations by year

Year: 2020 2001 2000 1999 1998 1996 1995 1994 1993 1992 Total
Citations: 2 2 2 1 3 3 2 1 4 3 23
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (23)

Title and authors Publication Year
Cysteinyl leukotriene metabolism of human eosinophils in allergic disease
J Miyata, K Fukunaga, Y Kawashima, O Ohara, M Arita
Allergology international : official journal of the Japanese Society of Allergology 2020
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
J Butterfield, CR Weiler
The Journal of Allergy and Clinical Immunology: In Practice 2020
Mutual activation of pulmonary fibroblasts and eosinophils, and modulation by drugs in relation to asthma
FM Spoelstra, DS Postma, HF Kauffman
Clinical & Experimental Allergy 2001
Advances in Prostaglandin and Leukotriene Research
B Samuelsson, R Paoletti, GC Folco, E Granström, S Nicosia
2001
Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts
GT Furuta, SJ Ackerman, J Varga, AM Spiess, MY Wang, BK Wershil
Clinical & Experimental Immunology 2000
The Leukotriene C 4 Synthase Gene and Asthma
TD Bigby
American journal of respiratory cell and molecular biology 2000
Cytokines in asthma
KF Chung, PJ Barnes
Thorax 1999
Asthma and Allergic Diseases
WJ Metzger, JA Nyce
Asthma and Allergic Diseases 1998
Lung Biology in Health and Disease: Amplification and Generation of Leukotrienes and Lipoxins by Transcellular Biosynthesis
T Bigby, B Levy, C Serhan
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 1998
Changes in CD11b and L-selectin Expression on Eosinophils Are Mediated by Human Lung Fibroblasts In Vitro
FM Spoelstra, H Hovenga, JA Noordhoek, DS Postma, HF Kauffman
American journal of respiratory and critical care medicine 1998
Biology and pathophysiology of leukotrienes
C Denzlinger
Critical Reviews in Oncology/Hematology 1996
Biology of interleukin-5 and its relevance to allergic disease
RW Egan, SP Umland, FM Cuss, RW Chapman
Allergy 1996
The eosinophil and its role in asthma
LH Thomas, JA Warner
General Pharmacology: The Vascular System 1996
Eosinophil function in health and disease
DS Silberstein
Critical Reviews in Oncology/Hematology 1995
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool
M Triggiani, A Oriente, MC Seeds, DA Bass, G Marone, FH Chilton
Journal of Experimental Medicine 1995
The role of peptide leukotrienes in renal failure induced by a tourniquet
T Tanaka, T Kita, N Tanaka
Forensic Science International 1994
Eosinophil Migration in Atopic Dermatitis I: Increased Migratory Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine, Neutrophil-Activating Factor, Platelet-Activating Factor, and Platelet Factor 4
PL Bruijnzeel, PH Kuijper, S Rihs, S Betz, RA Warringa, L Koenderman
Journal of Investigative Dermatology 1993
L-Tryptophan and the Eosinophilia-Myalgia Syndrome: Current Understanding of the Etiology and Pathogenesis
J Varga, SA Jimenez, J Uitto
Journal of Investigative Dermatology 1993
Comparison of two modified techniques for purifying blood eosinophils
M Laviolette, M Bossé, H Rocheleau, S Lavigne, C Ferland
Journal of Immunological Methods 1993
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury
S Nigam, KV Honn, LJ Marnett, TL Walden
1993
Opposing effects of tumor necrosis factor-α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine
S Takafuji, SC Bischoff, AL de Weck, CA Dahinden
European Journal of Immunology 1992
Roles of eosinophils in allergy
PF Weller
Current Opinion in Immunology 1992
Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4
BK Lam, K Xu, MB Atkins, KF Austen
Proceedings of the National Academy of Sciences 1992

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts